Skip to content

Clinical trials

Phase 3 Hepatitis C, Chronic trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C, Chronic Phase: Phase 3 Country / region: Poland Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20061
20073
20081
20101
20113
20123
20141
20173
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie4
Debiopharm International SA2
GlaxoSmithKline2
Human Genome Sciences Inc.2
Atea Pharmaceuticals, Inc.1
Bausch Health Americas, Inc.1
Gilead Sciences1
Hoffmann-La Roche1
Janssen Infectious Diseases BVBA1
Janssen-Cilag International NV1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C, Chronic19
Hepatitis C13
Hepatitis3
Fibrosis2
Renal Insufficiency, Chronic1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.